You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Effect of formulation and route of administration on the bioavailability of recombinant hirudin
- In: G37 - Manufacturing and good manufacturing practice IPS (part 1) on Wednesday, 5 September 2007, 9:00-11:45
- At: Beijing (China) (2007)
- Type: Presentations + Posters
- By: LIU, Yu (Peking University, Beijing, China)
- Co-author(s): Zhang, Qiang (Peking University, Beijing, China)
- Abstract:
The objective of our research was to study the effect of formulation and route of administration on the bioavailability of recombinant hirudin variant-2 (rHV2). Pharmacokinetics and pharmacodynamics of recombinant hirudin variant-2 (rHV2) which is an antithrombotic polypeptide were compared for four non-parenteral administration routes,
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026